Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin Effects on Exercise Intensity and AMPK
NCT02951260Completed
- Sponsor
- Rigshospitalet
- Start
- Oct 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Rigshospitalet. Primary endpoint: Overall aerobic work performed during an exercise bout with self-selected intensity at Day 17. Started Oct 2016; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02951260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02951260.